logo

For the Inventor, By the Inventor

Great Dunmow, United Kingdom

Sarah Christine Hobbs

This inventor holds 11 USPTO granted patents. Top assignees: Merck Sharp + Dohme Corp., Merck Sharpe & Dohme Corp.. Active years: 1997-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sarah Christine Hobbs. Retrieved from https://idiyas.com/inventor/sarah-christine-hobbs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 149(Granted Patents)


Location History:

  • Bishops Stortford, GB (1997)
  • Great Dunmow, GB (1998 - 2002)

Company Filing History:

goldMedal10 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal1 out of 36 
 
Merck Sharpe & Dohme Corp.
 patents

Years Active: 1997-2002

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6355638 - Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition (2002-03-12),
2. 6262103 - Thienycyclohexanone derivatives as ligands of the GABAA &agr;5 receptor subtype (2001-07-17),
3. 6156761 - Substituted tetralone derivatives for enhancing cognition (2000-12-05),
4. 5998415 - Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues (1999-12-07),
5. 5981529 - Substituted indolylpropyl-piperazine derivatives as 5-HT.sub.1D .alpha. (1999-11-09),
6. 5973156 - Piperidine and tetrahydropyridine derivatives (1999-10-26),
7. 5925638 - Substituted 1-indolylpropyl-4-benzylpiperazine derivatives (1999-07-20),
8. 5854268 - Azetidine, pyrrolidine and piperidine derivatives (1998-12-29),
9. 5807857 - Piperazine, piperidine and tetrahydropyridine derivative of (1998-09-15),
10. 5681833 - Benzodiazepine derivatives (1997-10-28),
11. 5618812 - Benzodiazepine derivatives (1997-04-08),

Title: The Innovative Contributions of Sarah Christine Hobbs

Introduction

Sarah Christine Hobbs is a distinguished inventor based in Great Dunmow, GB. She has made significant contributions to the field of cognitive enhancement through her innovative research and development of pharmaceutical compounds. With a total of 11 patents to her name, Hobbs has established herself as a leading figure in her area of expertise.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition." This patent focuses on compounds that act as GABA-A Alpha 5 ligands, which are useful for enhancing cognitive functions. Another notable patent involves thienycyclohexanone derivatives that serve as ligands of the GABAA α5 receptor subtype. This pharmaceutical composition comprises a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein A includes various chemical structures such as C, alkyl, C, alkenyl, C, alkynyl, C, cycloalkyl, arylC, alkyl, aryl, and S(O), R.

Career Highlights

Throughout her career, Sarah has worked with prominent companies, including Merck Sharp & Dohme Corp. and Merck Sharpe & Dohme Corp. Her work has been instrumental in advancing the understanding of cognitive enhancement through innovative pharmaceutical solutions.

Collaborations

Sarah has collaborated with notable professionals in her field, including Mark Stuart Chambers and Leslie Joseph Street. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

In summary, Sarah Christine Hobbs is a remarkable inventor whose work in cognitive enhancement has led to significant advancements in pharmaceutical science. Her numerous patents and collaborations highlight her dedication to innovation and her impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…